Association of prior interferon-alpha treatment with the efficacy of adjuvant pembrolizumab in resected melanoma.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e22100
Abstract: e22100Background: Adjuvant pembrolizumab or interferon-alpha has been found to prolong recurrence-free survival as adjuvant therapy for resected melanoma. Several studies have shown that interferon... read more here.
Keywords: resected melanoma; association prior; interferon alpha; adjuvant pembrolizumab ... See more keywords